---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-089806"
form_type: "8-K"
ticker: "EVGO"
cik: "0001821159"
company_name: "EVgo Inc."
filed_at: "2023-08-10T23:59:59+00:00"
generated_at: "2026-06-11T18:53:46.630272+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# EVgo receives Nasdaq deficiency notice for audit committee vacancy; cure period through mid-2024

## Summary
- Non-compliance due to Badar Khan's departure from the Audit Committee.
- Cure period ends at earlier of next annual meeting or Aug 1, 2024.
- If 2024 annual meeting before Jan 29, 2024, compliance due by Jan 29, 2024.
- Company evaluating committee membership and intends to regain compliance.
- Notice has no immediate effect on listing or trading of EVGO or EVGOW.

## SEC filing metadata
- accession: 0001104659-23-089806
- form_type: 8-K
- ticker: EVGO
- cik: 0001821159
- company_name: EVgo Inc.
- filed_at: 2023-08-10T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1821159/000110465923089806/0001104659-23-089806-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1821159/000110465923089806/tm2323345d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-089806
- JSON: https://secwatch.observer/filing/0001104659-23-089806.json
- Plain text: https://secwatch.observer/filing/0001104659-23-089806.txt

## Key facts
- Listing & Compliance Notices
  EVgo Inc. received a nasdaq noncompliance notice notice regarding audit committee (rules 5605).
  - Exchange: nasdaq
  - Notice: noncompliance notice
  - Deficiency: audit committee
  - Rules: 5605
  source text: August 8, 2023, the Company received a written notice (the “ Letter ”) from Nasdaq’s Listing Qualifications Department confirming that, as a result of Mr. Badar Khan’s departure from the Audit Committee, the Company is no longer in compliance with Nasdaq’s audit committee composition requirement set forth in Nasdaq Listing Rule 5605. The Letter is only a notification of deficiency and has no current effect on the listing or trading of the Company’s securities on Nasdaq. The Letter states that, consistent with Nasdaq Listing Rule 5605(c)(4), Nasdaq will provide the Company with a cure period in
  evidence_url: https://www.sec.gov/Archives/edgar/data/1821159/000110465923089806/0001104659-23-089806-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.